Chemed (NYSE:CHE) Hits New 52-Week High – Here’s Why

Shares of Chemed Corporation (NYSE:CHE) hit a new 52-week high during trading on Thursday . The stock traded as high as $485.98 and last traded at $482.92, with a volume of 11472 shares. The stock had previously closed at $480.87.

Analysts Set New Price Targets

A number of research analysts have weighed in on CHE shares. Royal Bank Of Canada lifted their price target on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Weiss Ratings raised shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Finally, Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $501.50.

Chemed Trading Down 0.0%

The company has a market cap of $6.50 billion, a P/E ratio of 26.68, a PEG ratio of 1.81 and a beta of 0.52. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. The business has a 50 day moving average price of $436.14 and a 200-day moving average price of $426.84.

Chemed (NYSE:CHE) last released its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating the consensus estimate of $5.30 by $0.35. The business had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The firm’s revenue was up 1.6% on a year-over-year basis. During the same period last year, the business earned $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Analysts forecast that Chemed Corporation will post 22.67 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were paid a dividend of $0.60 per share. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. Chemed’s payout ratio is currently 13.08%.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director owned 4,578 shares of the company’s stock, valued at $2,047,876.74. The trade was a 22.73% decrease in their position. The disclosure for this sale is available in the SEC filing. 3.33% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. SG Americas Securities LLC boosted its position in shares of Chemed by 773.5% during the 4th quarter. SG Americas Securities LLC now owns 26,466 shares of the company’s stock worth $11,324,000 after acquiring an additional 23,436 shares in the last quarter. Intech Investment Management LLC acquired a new position in Chemed during the third quarter valued at approximately $1,429,000. BNP Paribas Financial Markets raised its position in Chemed by 14.5% during the fourth quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock valued at $14,985,000 after purchasing an additional 4,430 shares in the last quarter. Abacus FCF Advisors LLC bought a new stake in Chemed during the fourth quarter worth $5,935,000. Finally, C WorldWide Group Holding A S bought a new stake in Chemed during the fourth quarter worth $2,189,000. 95.85% of the stock is owned by institutional investors and hedge funds.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.